ATLANTA, GA--(MARKET WIRE)--Jul 6, 2006 -- AtheroGenics, Inc. (NASDAQ:AGIX - News), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it expects to release its second quarter 2006 results of operations on Thursday, July 20, 2006, before the U.S. financial markets open.
